$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 12 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 14.52 | 132,800 | 1,928,256 | 467,200 | |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 15.31 | 467,200 | 7,152,832 | 10,000 | 477.2 K to 10 K (-97.90 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 14.52 | 467,200 | 6,783,744 | 477,200 | 10 K to 477.2 K (+4,672.00 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 15.02 | 132,800 | 1,994,656 | 10,000 | 142.8 K to 10 K (-93.00 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 14.52 | 132,800 | 1,928,256 | 142,800 | 10 K to 142.8 K (+1,328.00 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 15.02 | 15,000 | 225,300 | 16,450 | 31.5 K to 16.5 K (-47.69 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 8.81 | 15,000 | 132,150 | 31,450 | 16.5 K to 31.5 K (+91.19 %) |
| Nov 04 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 11.38 | 9,900 | 112,662 | 0 | |
| Nov 04 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.78 | 9,900 | 136,422 | 3,751 | 13.7 K to 3.8 K (-72.52 %) |
| Nov 04 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 11.38 | 9,900 | 112,662 | 13,651 | 3.8 K to 13.7 K (+263.93 %) |
| Sep 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| Sep 25 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 12.70 | 45,000 | 571,500 | 45,000 | |
| May 19 2014 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP Drug Developmen ... | Option Exercise | A | 11.04 | 550,000 | 6,072,000 | 550,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 12.43 | 42,500 | 528,275 | 42,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 12.43 | 42,500 | 528,275 | 42,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 12.43 | 225,000 | 2,796,750 | 225,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 12.43 | 225,000 | 2,796,750 | 225,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 12.43 | 87,500 | 1,087,625 | 87,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 12.43 | 87,500 | 1,087,625 | 87,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Medve Robert | SVP & Chief Medical ... | Option Exercise | A | 12.43 | 12,500 | 155,375 | 12,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Medve Robert | SVP & Chief Medical ... | Option Exercise | A | 12.43 | 12,500 | 155,375 | 12,500 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 12.43 | 85,000 | 1,056,550 | 85,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 12.43 | 85,000 | 1,056,550 | 85,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev and ... | Option Exercise | A | 12.43 | 50,000 | 621,500 | 50,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev and ... | Option Exercise | A | 12.43 | 50,000 | 621,500 | 50,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 12.43 | 50,000 | 621,500 | 50,000 | |
| Feb 07 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 12.43 | 50,000 | 621,500 | 50,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Sep 23 2013 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 13.80 | 40,000 | 552,000 | 40,000 | |
| Aug 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 11.41 | 12,500 | 142,625 | 0 | |
| Aug 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Sell | S | 12.41 | 12,500 | 155,125 | 20,000 | 32.5 K to 20 K (-38.46 %) |
| Aug 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 11.41 | 12,500 | 142,625 | 32,500 | 20 K to 32.5 K (+62.50 %) |
| Aug 07 2013 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 11.41 | 12,500 | 142,625 | 0 | |
| Aug 07 2013 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Sell | S | 12.41 | 12,500 | 155,125 | 20,000 | 32.5 K to 20 K (-38.46 %) |
| Aug 07 2013 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 11.41 | 12,500 | 142,625 | 32,500 | 20 K to 32.5 K (+62.50 %) |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | A | 8.80 | 37,500 | 330,000 | 37,500 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | A | 8.80 | 37,500 | 330,000 | 37,500 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev and ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev and ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Medve Robert | Chief Medical Offic ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Medve Robert | Chief Medical Offic ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | Chief Scientific Of ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | Chief Scientific Of ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 8.80 | 92,500 | 814,000 | 92,500 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 8.80 | 92,500 | 814,000 | 92,500 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 8.80 | 75,000 | 660,000 | 75,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 8.80 | 75,000 | 660,000 | 75,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 8.80 | 225,000 | 1,980,000 | 225,000 | |
| Feb 08 2013 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 8.80 | 225,000 | 1,980,000 | 225,000 | |
| Feb 04 2013 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Feb 04 2013 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 0.00 | 7,500 | 0 | 50,833 | 43.3 K to 50.8 K (+17.31 %) |
| Dec 14 2012 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Dec 14 2012 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Buy | M | 0.00 | 7,500 | 0 | 11,250 | 3.8 K to 11.3 K (+200.00 %) |
| Oct 01 2012 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 8.66 | 12,500 | 108,250 | 0 | |
| Oct 01 2012 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Sell | S | 10.66 | 12,500 | 133,250 | 20,000 | 32.5 K to 20 K (-38.46 %) |
| Oct 01 2012 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 8.66 | 12,500 | 108,250 | 32,500 | 20 K to 32.5 K (+62.50 %) |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Buy | P | 9.18 | 5,000 | 45,908 | 5,000 | 0 to 5 K |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Sep 18 2012 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 9.24 | 40,000 | 369,600 | 40,000 | |
| Jul 17 2012 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 6.12 | 24,001 | 146,886 | 0 | |
| Jul 17 2012 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 8.50 | 24,001 | 204,009 | 260,623 | 284.6 K to 260.6 K (-8.43 %) |
| Jul 17 2012 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 6.12 | 24,001 | 146,886 | 284,624 | 260.6 K to 284.6 K (+9.21 %) |
| Jun 28 2012 | NKTR | NEKTAR THERAPEUTIC ... | Medve Robert | Chief Medical Offic ... | Option Exercise | A | 8.01 | 150,000 | 1,201,500 | 150,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | Chief Scientific Of ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | Chief Scientific Of ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 7.21 | 75,000 | 540,750 | 75,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 7.21 | 75,000 | 540,750 | 75,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 7.21 | 200,000 | 1,442,000 | 200,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 7.21 | 200,000 | 1,442,000 | 200,000 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | A | 7.21 | 37,500 | 270,375 | 37,500 | |
| Feb 10 2012 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | A | 7.21 | 37,500 | 270,375 | 37,500 | |
| Dec 14 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Dec 14 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Sep 15 2011 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 5.14 | 30,000 | 154,200 | 30,000 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 0.00 | 3,333 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 0.00 | 3,333 | 0 | 43,333 | 40 K to 43.3 K (+8.33 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Buy | M | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Buy | M | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | M | 0.00 | 1,089 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Buy | M | 0.00 | 1,089 | 0 | 14,386 | 13.3 K to 14.4 K (+8.19 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 0.00 | 10,000 | 0 | 16,450 | 6.5 K to 16.5 K (+155.04 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 0.00 | 1,089 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 0.00 | 1,089 | 0 | 3,057 | 2 K to 3.1 K (+55.34 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 9.00 | 4,500 | 40,500 | 255,709 | 260.2 K to 255.7 K (-1.73 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 0.00 | 10,000 | 0 | 260,209 | 250.2 K to 260.2 K (+4.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 0.00 | 5,000 | 0 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | M | 0.00 | 550 | 0 | 0 | |
| Mar 09 2011 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Buy | M | 0.00 | 550 | 0 | 2,499 | 1.9 K to 2.5 K (+28.22 %) |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 10.69 | 90,000 | 962,100 | 90,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 10.69 | 75,000 | 801,750 | 75,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | Chief Scientific Of ... | Option Exercise | A | 10.69 | 60,000 | 641,400 | 60,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Ghosh Rinko | Chief Business Offi ... | Option Exercise | A | 10.69 | 100,000 | 1,069,000 | 100,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 10.69 | 63,000 | 673,470 | 63,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 10.69 | 300,000 | 3,207,000 | 300,000 | |
| Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 10.69 | 30,000 | 320,700 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| Sep 16 2010 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 14.05 | 30,000 | 421,500 | 30,000 | |
| May 12 2010 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 6.12 | 35,000 | 214,200 | 24,004 |